Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | NCOA3 |
Upstream (Parents) |
---|
(<<) BMPR2 → NCOA3 |
(<<) CASKIN1 → NCOA3 |
(<<) COIL → NCOA3 |
(<<) KCTD12 → NCOA3 |
(<<) NFAT5 → NCOA3 |
(<<) PPP2R5C → NCOA3 |
(<<) RHOD → NCOA3 |
(<<) SMAD5 → NCOA3 |
(<<) SYK → NCOA3 |
(<<) WASF2 → NCOA3 |
(<<) WBP4 → NCOA3 |
Downstream (Children) |
---|
NCOA3 → BAD (>>) |
NCOA3 → CBL (>>) |
NCOA3 → CDK6 (>>) |
NCOA3 → CHST13 (>>) |
NCOA3 → EIF4E (>>) |
NCOA3 → ELF1 (>>) |
NCOA3 → HSPA4 (>>) |
NCOA3 → KRAS (>>) |
NCOA3 → MAP1B (>>) |
NCOA3 → MAP3K5 (>>) |
NCOA3 → MYO1E (>>) |
NCOA3 → NFKBIZ (>>) |
NCOA3 → NRIP1 (>>) |
NCOA3 → PDPK1 (>>) |
NCOA3 → PPP1R12B (>>) |
NCOA3 → RAC3 (>>) |
NCOA3 → TCF4 (>>) |
NCOA3 → TMEM87B (>>) |
NCOA3 → WNT3 (>>) |
NCOA3 → YWHAB (>>) |